title: Insulin regulation of glutathione and contractile phenotype in diabetic rat ventricular myocytes.
abstract: Cardiovascular complications of diabetes mellitus involve oxidative stress and profound changes in reduced glutathione (GSH), an essential tripeptide that controls many redox-sensitive cell functions. This study examined regulation of GSH by insulin to identify mechanisms controlling cardiac redox state and to define the functional impact of GSH depletion. GSH was measured by fluorescence microscopy in ventricular myocytes isolated from Sprague-Dawley rats made diabetic by streptozotocin, and video and confocal microscopy were used to measure mechanical properties and Ca(2+) transients, respectively. Spectrophotometric assays of tissue extracts were also done to measure the activities of enzymes that control GSH levels. Four weeks after injection of streptozotocin, mean GSH concentration ([GSH]) in isolated diabetic rat myocytes was approximately 36% less than in control, correlating with decreased activities of two major enzymes regulating GSH levels: glutathione reductase and gamma-glutamylcysteine synthetase. Treatment of diabetic rat myocytes with insulin normalized [GSH] after a delay of 3-4 h. A more rapid but transient upregulation of [GSH] occurred in myocytes treated with dichloroacetate, an activator of pyruvate dehydrogenase. Inhibitor experiments indicated that insulin normalized [GSH] via the pentose pathway and gamma-glutamylcysteine synthetase, although the basal activity of glucose-6-phosphate dehydrogenase was not different between diabetic and control hearts. Diabetic rat myocytes were characterized by significant mechanical dysfunction that correlated with diminished and prolonged Ca(2+) transients. This phenotype was reversed by in vitro treatment with insulin and also by exogenous GSH or N-acetylcysteine, a precursor of GSH. Our data suggest that insulin regulates GSH through pathways involving de novo GSH synthesis and reduction of its oxidized form. It is proposed that a key function of glucose metabolism in heart is to supply reducing equivalents required to maintain adequate GSH levels for the redox control of Ca(2+) handling proteins and contraction.
authors.affiliation: Dept of Cellular and Integrative Physiology, Univ of Nebraska College of Medicine, 985850 Nebraska Medical Center, Omaha, NE 68198-5850, USA.
authors.forename: Shumin
authors.initials: S
authors.lastname: Li
authors.forename: Xun
authors.initials: X
authors.lastname: Li
authors.forename: Yu-Long
authors.initials: YL
authors.lastname: Li
authors.forename: Chun-Hong
authors.initials: CH
authors.lastname: Shao
authors.forename: Keshore R
authors.initials: KR
authors.lastname: Bidasee
authors.forename: George J
authors.initials: GJ
authors.lastname: Rozanski
mesh_terms: D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology*; D005978:Glutathione / Q000378:metabolism*; D006352:Heart Ventricles / Q000187:drug effects / Q000503:physiopathology*; D007328:Insulin / Q000494:pharmacology*; D008297:Male; D032342:Muscle Cells / Q000187:drug effects / Q000502:physiology*; D009200:Myocardial Contraction / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012016:Reference Values; D013311:Streptozocin; D016276:Ventricular Function
chemical_list: D007328:Insulin; D013311:Streptozocin; D005978:Glutathione